PDCD10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.105600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.433200E-01
Normal-vs-Stage2
8.098200E-01
Normal-vs-Stage3
3.327800E-01
Normal-vs-Stage4
4.420400E-01
Stage1-vs-Stage2
5.334400E-01
Stage1-vs-Stage3
4.869800E-01
Stage1-vs-Stage4
2.894600E-01
Stage2-vs-Stage3
1.770210E-01
Stage2-vs-Stage4
2.399400E-01
Stage3-vs-Stage4
1.782180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.219600E-01
Normal-vs-AfricanAmerican
8.838400E-01
Normal-vs-Asian
8.778200E-01
Caucasian-vs-AfricanAmerican
9.329400E-01
Caucasian-vs-Asian
6.380200E-01
AfricanAmerican-vs-Asian
7.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.175000E-01
Normal-vs-Female
8.966800E-01
Male-vs-Female
9.409400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.371000E-01
Normal-vs-Age(41-60Yrs)
6.326600E-01
Normal-vs-Age(61-80Yrs)
9.486400E-01
Normal-vs-Age(81-100Yrs)
9.535400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.930360E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.721400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.263600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.235600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.133800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.204400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.507200E-01
Normal-vs-Daily Drinker
7.703800E-01
Normal-vs-Weekly Drinker
5.341600E-01
Normal-vs-Occasional Drinker
5.040800E-01
Normal-vs-Social Drinker
8.667600E-01
Non Drinker-vs-Daily Drinker
6.393800E-01
Non Drinker-vs-Weekly Drinker
3.734800E-01
Non Drinker-vs-Occasional Drinker
1.344440E-01
Non Drinker-vs-Social Drinker
6.861800E-01
Daily Drinker-vs-Weekly Drinker
6.413400E-01
Daily Drinker-vs-Occasional Drinker
6.958100E-02
Daily Drinker-vs-Social Drinker
4.140000E-01
Weekly Drinker-vs-Occasional Drinker
3.944000E-02
Weekly Drinker-vs-Social Drinker
2.095600E-01
Occasional Drinker-vs-Social Drinker
3.189800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.645350E-01
Normal-vs-Grade 2
5.478400E-03
Normal-vs-Grade 3
8.383100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.637900E-04
Grade 1-vs-Grade 3
5.6531999999998E-05
Grade 1-vs-Grade 4
1.645350E-01
Grade 2-vs-Grade 3
5.354000E-02
Grade 2-vs-Grade 4
5.478400E-03
Grade 3-vs-Grade 4
8.383100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.120600E-01
Normal-vs-NonDiabetic
9.578800E-01
Diabetic-vs-NonDiabetic
3.595000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.001400E-01
Normal-vs-NoPancreatitis
9.887200E-01
Pancreatitis-vs-NoPancreatitis
4.986000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.535800E-01
Normal-vs-N1
8.094600E-01
N0-vs-N1
3.002600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.144000E-01
Normal-vs-TP53-NonMutant
8.070600E-01
TP53-Mutant-vs-TP53-NonMutant
1.02690000003403E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
